
[Expand/Collapse all sections]Expand all

This document outlines details of PBS-subsidised somatropin for patients
with childhood onset or late onset of severe growth hormone deficiency,
previously known as ‘adult growth hormone deficiency (AGHR)’.

Severe growth hormone deficiency and listing dates

Severe growth hormone deficiency is a condition where the body is unable
to produce enough hormone which impairs the growth and development of
adults.

Listing date:

-   somatropin - 1 December 2018

See Written Authority Required Drugs for more information.

Treatment specifics

Somatropin is not PBS-subsidised for patients with Prader-Willi Syndrome
aged 18 years or older without a documented childhood-onset growth
hormone deficiency.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, contact details,
item and restriction codes, the PBS schedule and the Services Australia
website.

Related links

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing written authority approval request

Processing Complex Authority Required Listings

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
